ANDA 86890, held by Watson Labs Teva. Disulfiram.
As of Nov 16, 2026, ANDA 86890 (Disulfiram), held by Watson Labs Teva, was first approved by FDA on Mar 31, 1981, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 31, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Disulfiram500MG ยท tablet;oral | Disulfiram | Discontinued |
| Apr 14, 1998 | Supplement 22Labeling | Approved | None posted |
| May 13, 1992 | Supplement 21Manufacturing | Approved | None posted |
| May 31, 1991 | Supplement 18Manufacturing | Approved | None posted |
| Jan 28, 1991 | Supplement 19Manufacturing | Approved | None posted |
| Jun 29, 1990 | Supplement 17Manufacturing | Approved | None posted |
| Oct 14, 1988 | Supplement 15Manufacturing | Approved | None posted |
| Oct 14, 1988 | Supplement 14Manufacturing | Approved | None posted |
| Aug 29, 1985 | Supplement 12Manufacturing | Approved | None posted |
| Aug 29, 1985 | Supplement 11Manufacturing | Approved | None posted |
| Aug 29, 1985 | Supplement 10Manufacturing | Approved | None posted |
| May 26, 1982 | Supplement 8Manufacturing | Approved | None posted |
| Mar 31, 1981 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters